khosrow khalifeh | Biotechnology | Best Researcher Award

Published on by Research Hypothesis

khosrow khalifeh | Biotechnology | Best Researcher Award

Assoc. Prof. Dr khosrow khalifeh, University of Zanjan, Iran

Assoc. Prof. Dr. Khosrow Khalifeh is a leading Iranian biophysicist whose academic journey and research excellence have significantly advanced the fields of protein folding, bioinformatics, and molecular biophysics. Currently serving at the University of Zanjan, he specializes in investigating the structural dynamics of biomolecules and their functional interactions using experimental and computational approaches. His multidisciplinary teaching spans biophysical chemistry, radiation biology, and computational molecular biology. Dr. Khalifeh has authored several impactful publications in peer-reviewed journals and contributed chapters to prestigious Elsevier volumes. He is also known for pioneering work on luciferase proteins, chondroitinase enzymes, and the computational analysis of photoproteins. With over a decade of academic and research experience, his work not only enhances scientific understanding but also holds promise in areas like neurobiology and drug resistance. Dr. Khalifeh stands out as a deserving nominee for the Best Researcher Award due to his scholarly contributions, innovation, and commitment to education.

Publication Profile

Google Scholar

Education

Dr. Khosrow Khalifeh’s academic foundation is deeply rooted in the biological sciences and biophysics. He earned his Ph.D. in Biophysics from Tarbiat Modarres University, Tehran, in 2010. His doctoral research focused on the kinetic and thermodynamic behavior of wild-type and mutant Firefly Luciferase (Lampyris turkestanicus), exploring the complexities of protein folding and unfolding. He obtained his Master’s degree in Biophysics from the same institution in 2005, working on chemical modification of lysozyme and its impact on protein refolding kinetics. Prior to that, he completed his Bachelor of Science in Biology from Shahid Chamran University, Ahvaz, in 2000. His educational journey, characterized by strong theoretical and practical engagement with protein chemistry, molecular interactions, and biophysical mechanisms, has laid a solid groundwork for his later work in advanced biomolecular research and computational biology.

Experience

Dr. Khalifeh began his academic career as an Assistant Professor of Biophysics at the University of Zanjan in 2010. Over the next seven years, he actively contributed to teaching and research in molecular biophysics, eventually being promoted to Associate Professor in 2017. His teaching portfolio is extensive, including courses such as Biophysical Chemistry, Molecular Biophysics, Radiation Biophysics, Bioinformatics, and Biological Sequence Analysis. He also covers advanced topics like computational molecular biology and the philosophy of biology. Throughout his tenure, his teaching evaluations have consistently exceeded expectations, reflecting his commitment to academic excellence. His research integrates experimental biophysics and computational simulations, mentoring numerous graduate students while collaborating with national and international researchers. Dr. Khalifeh has built a reputation for combining innovative methodologies with solid pedagogical skills, and his ongoing efforts continue to shape the next generation of biophysicists in Iran and beyond.

Awards and Honors

Although specific awards and honors are not listed in the provided data, Assoc. Prof. Dr. Khosrow Khalifeh’s distinguished academic trajectory and peer recognition can be inferred from his consistently high teaching evaluations, publication record, and contributions to edited volumes by Academic Press (Elsevier). His selection as a co-author for high-impact book chapters such as “Spectroscopic Methods to Study Protein Folding Kinetics” and “Chondroitinase ABC I in Spinal Cord Injury” speaks volumes about his expertise and scientific standing. Dr. Khalifeh’s work has been published in reputable journals like International Journal of Biological Macromolecules, Spectrochimica Acta, Luminescence, European Biophysics Journal, and Scientific Reports. These accomplishments reflect peer recognition and academic influence, establishing him as a key thought leader in his field. His eligibility for the Best Researcher Award is further strengthened by this solid academic footprint and the originality of his contributions to biophysical research.

Research Focus

Dr. Khosrow Khalifeh’s research spans the intersecting domains of biophysics, bioinformatics, systems biology, and biotechnology. His primary focus lies in understanding protein folding and unfolding mechanisms, enzyme dynamics, and molecular interactions using both wet-lab experiments and in silico simulations. He has significantly contributed to the molecular study of photoproteins such as Mnemiopsin and enzymes like Chondroitinase ABC I and cyclomaltodextrinase. His research employs molecular dynamics simulations, structural modeling, and thermodynamic profiling to explore the functional consequences of site-directed mutations and ligand binding. Additionally, he has investigated protein-DNA interactions, protein engineering, and the biochemical effects of mutation-induced charge shifts, offering insights into disease-related protein dysfunctions and potential biotechnological applications. This cross-disciplinary focus positions Dr. Khalifeh at the cutting edge of biomolecular and computational biophysics, making his work highly impactful for both theoretical understanding and translational science.

Publication Top Notes

Interaction of lysozyme with gold nanorods: conformation and activity investigations

Roles of trehalose and magnesium sulfate on structural and functional stability of firefly luciferase

Thermodynamics of protein folding: methodology, data analysis and interpretation of data

Effect of arginine on pre-nucleus stage of interferon beta-1b aggregation

Critical role of a loop at C-terminal domain on the conformational stability and catalytic efficiency of chondroitinase ABC I

OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells

The role of trehalose for metastable state and functional form of recombinant interferon beta-1b

Rajkumar Maiti | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Rajkumar Maiti | Biology and Life Sciences | Best Researcher Award

Dr Rajkumar Maiti, Bankura Christian College, India

Dr. Rajkumar Maiti is a distinguished Indian physiologist and researcher, currently serving as Associate Professor at Bankura Christian College, West Bengal. With over two decades of academic and research experience, Dr. Maiti has significantly contributed to the fields of Physiology, Sports Science, Ergonomics, and Herbal Pharmacology. He obtained his Ph.D. in 2007 from Vidyasagar University, focusing on the hypoglycemic effects of Tamarindus indica in diabetic models. Dr. Maiti is recognized for his work in herbal drug development, environmental health, and human performance, publishing over 60 research articles in Scopus-indexed international journals. His interdisciplinary approach bridges traditional medicine with modern science, earning him accolades such as the NESA Eminent Scientist Award (2023) and Research & Publication Award (2024). He is also a registered patent holder. Through his research, Dr. Maiti continues to explore sustainable biomedical innovations while mentoring young researchers and guiding Ph.D. candidates in their scientific pursuits.

Publication Profile

Google Scholar

Education

Dr. Rajkumar Maiti has a strong academic foundation in Physiology and Education. He earned his B.Sc. in Physiology from Vidyasagar University in 1997, followed by an M.Sc. in Physiology with specialization in Ergonomics, Sports Physiology, and Human Performance in 1999. Demonstrating his commitment to pedagogy, he also completed a B.Ed. in 2000 from the same university. His academic journey culminated in a Ph.D. in Physiology (Science) in 2007, where his research focused on the hypoglycemic potential of Tamarindus indica seed extract in managing insulin-dependent diabetes mellitus. This education laid a robust interdisciplinary platform integrating biological sciences, education, and applied research in health. Dr. Maiti’s academic versatility is further reflected in his guidance of Ph.D. scholars and his extensive publication record in emerging biomedical domains such as phytotherapy, toxicology, and clinical nutrition.

Experience

Dr. Rajkumar Maiti brings over 13 years of teaching and research experience, starting as an Assistant Professor at Bankura Christian College on 5th November 2011. His exceptional academic performance and research achievements led to his promotion to Associate Professor on 5th November 2023, a position he currently holds. Over the years, he has mentored students and scholars in advanced physiological concepts, nutritional science, sports physiology, and clinical aspects of human performance. Dr. Maiti’s work extends beyond the classroom, contributing extensively to empirical research, guiding Ph.D. candidates, and developing patented innovations. His scholarly outputs reflect a strong commitment to applied science and societal well-being, particularly in tribal health, diabetes management, reproductive toxicology, and environmental health hazards. His dedication to both pedagogy and empirical science makes him a pivotal figure in India’s physiological research landscape.

Awards and Honors

Dr. Rajkumar Maiti has been recognized nationally for his outstanding contributions to science and education. His accolades include the Prof. B. B. Sarkar Memorial Oration Award (2019) from the Physiological Society of India and multiple prestigious recognitions from the National Environmental Science Academy (NESA): Distinguished Scientist of the Year Award (2022), Environmentalist of the Year Award (2023), and Eminent Scientist of the Year Award (2023). In 2024, he received the Research and Publication Award from Bankura Christian College via the IRINS Portal for his prolific publication record. Additionally, he is the inventor of a patented design titled “Design of a Special Bed for Aged Individuals and Patients Suffering from Urinary Incontinence” (Design No. 400946-001, Govt. of India, 2023). These honors underscore his interdisciplinary impact on health science, environmental awareness, and biomedical innovation.

Research Focus

Dr. Rajkumar Maiti’s research is driven by a deep interest in applied human physiology and translational medicine. His key focus areas include herbal antidiabetic drug development, nutritional and psychological profiling of tribal adolescents, and correction of chemically induced reproductive toxicity. His groundbreaking studies on Tamarindus indica, fluoride, and cyclophosphamide offer critical insights into the use of phytomedicine to combat metabolic and reproductive disorders. He also explores ergonomics, sports physiology, and clinical nutrition, promoting holistic health through evidence-based approaches. In recent years, his work expanded into nanotechnology applications in medicine, environmental toxicology, and infectious diseases, bridging traditional science with modern biomedical applications. He holds one patent and is actively engaged in guiding Ph.D. research. With over 60 international publications indexed in Scopus, his work has made meaningful contributions to both academic scholarship and public health policy.

Publication Top Notes

Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats

Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica

Testicular toxicity in sodium fluoride treated rats: association with oxidative stress

In vitro determination of the contraceptive spermicidal activity of a composite extract of Achyranthes aspera and Stephania hernandifolia on human semen

Comparative study on antihyperglycemic and antihyperlipidemic effects of separate and composite extract of seed of Eugenia jambolana and root of Musa paradisiaca in …

Management of fluoride induced testicular disorders by calcium and vitamin-E co-administration in the albino rat

Fluoride-induced immunotoxicity in adult male albino rat: a correlative approach to oxidative stress

Effect of aqueous extract of leaf of Aegle marmelos on testicular activities in rats

Antidiabetogenic effects of separate and composite extract of seed of Jamun (Eugenia jambolana) and root of Kadali (Musa paradisiaca) in streptozotocin-induced diabetic male …

 

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Published on by Research Hypothesis

Mar Villamiel | Biology and Life Sciences | Women Researcher Award

Dr Mar Villamiel, CIAL, CSIC-UAM, Spain

Dr. Mar Villamiel is the Director of CIAL (Institute of Food Science Research, CSIC-UAM) in Spain and leads the PREBIOIN research group focused on carbohydrate functionality and food bioactivity. With a PhD in Pharmacy from Complutense University of Madrid, she specializes in food technology, bioactive carbohydrates, and sustainable food preservation. Her innovative research centers on extracting and characterizing pectin and other functional ingredients from agri-food by-products. Dr. Villamiel has coordinated over 70 research projects and contracts, published 173 JCR articles (h-index: 46 WoS), co-authored 20 book chapters, and holds 7 patents. Her work has earned her national and international recognition, including being named among the Top 2% of Scientists worldwide by Stanford University. Passionate about science communication, she has presented at over 150 conferences and supervised more than 50 academic theses and internships globally. Her commitment to sustainability and technological advancement defines her as a leading force in food science research.

Publication Profile

Orcid

Education

Dr. Mar Villamiel completed her undergraduate degree in Pharmacy at Complutense University of Madrid in 1991 and earned her PhD in Pharmacy from the same institution in 1995. Her doctoral studies laid the groundwork for a highly interdisciplinary research career, incorporating analytical chemistry, food technology, and functional foods. Postdoctoral work in the Netherlands and professional exchanges in the UK expanded her knowledge in sustainable food preservation and the development of bioactive food compounds. Her deep educational foundation has supported her leadership in developing advanced methodologies in food science. Through ongoing academic collaborations and international stays, she continues to enhance her expertise and contribute to global education, mentoring students and researchers across Europe, Latin America, and beyond. Her academic path reflects a consistent trajectory of excellence, innovation, and dedication to research in food bioactivity and sustainable processing technologies. 🎓🔍📘🌍

Experience

Dr. Villamiel has over two decades of experience in food science research, beginning her career as a Tenured Scientist at CSIC (2000–2009). She later served as Deputy Director (2017–2019) and is currently the Director of CIAL since March 2021. She leads the PREBIOIN group, which explores carbohydrate functionality, pectin extraction, and sustainable food technologies. She has led 8 international projects, 34 industry contracts, and 72 total projects, often as Principal Investigator. She has published widely, mentored numerous PhDs (including international awardees), and edited prestigious scientific journals. Her collaborations span across institutions in Europe, Latin America, and Asia. She actively participates in EU regulatory panels and scientific committees and has received 10 research awards. Her interdisciplinary approach and leadership have made significant impacts in agri-food revalorization, food preservation, and nutritional functionality.

Awards and Honors

Dr. Mar Villamiel’s outstanding contributions have earned her numerous accolades, including 10 research awards and inclusion in the Stanford–Elsevier World’s Top 2% Scientists list in 2024. She has received five positive evaluations for six-year research periods, attesting to the sustained quality and impact of her work. Her research achievements include 7 patents (2 international), 173 JCR-indexed publications, and leadership of multi-million-euro research projects. She has served as an editor for major scientific journals and been an invited speaker at 17 international conferences. Her innovative methodologies in pectin extraction and bioactive compound analysis have been recognized with top conference awards, including First Prize at the Food Chemistry Conference (2023). She represents CSIC on platforms like the Biobased Industries Consortium and Food for Life. Her awards reflect her global influence, scientific leadership, and unwavering commitment to advancing sustainable food research.

Research Focus

Dr. Villamiel’s research focuses on the chemistry and functionality of carbohydrates, particularly pectins derived from agri-food by-products. She pioneers green extraction technologies such as ultrasound and subcritical water methods to obtain high-value bioactive compounds. Her work contributes significantly to sustainable food systems, enabling revalorization of food waste and enhancing nutritional profiles of food products. She leads multiple international collaborations and has developed in vitro digestion models to study carbohydrate behavior in the human gut. Her research addresses pressing challenges in food preservation, functional ingredient development, and biorefinery approaches for the food industry. With 173 publications, a high h-index (47 Scopus), and leadership in EU and Latin American projects, she is at the forefront of innovation in food science. Her contributions support public health, environmental sustainability, and industrial competitiveness through novel bioactive food solutions.

Publication Top Notes

Flours from popped grains: Physicochemical, thermal, rheological, and techno-functional properties

Use of natural low‐methoxyl pectin from sunflower by‐products for the formulation of low‐sucrose strawberry jams

Integral use of pectin-rich by-products in a biorefinery context: A holistic approach

Apple pomaces derived from mono-varietal Asturian ciders production are potential source of pectins with appealing functional properties

Application of sunflower pectin gels with low glycemic index in the coating of fresh strawberries stored in modified atmospheres

Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Published on by Research Hypothesis

Jwee Chiek Er | Biology and Life Sciences | Pioneer Researcher Award

Researcher, Norwegian Veterinary Institution, Norway

Dr. Jwee Chiek Er is a distinguished veterinary epidemiologist and researcher dedicated to advancing animal health. 🐖📈 Since 2007, he has worked full-time at the Norwegian Veterinary Institute, focusing on epidemiology and bioinformatics. 🇳🇴🔬 He also serves part-time as a church servant at Uranienborg Menighet since 2020. ⛪ Previously, Dr. Er contributed significantly to veterinary inspection in Singapore’s pig and poultry slaughterhouses (1991–2006) and served as a Captain in the Singapore Armed Forces (1989–1991). 🛡️🏥 With a Ph.D. from the University of Life Sciences, Norway, an MPVM from UC Davis, and a BVSc from the University of Queensland, Dr. Er’s career blends scientific excellence with public service. 🎓🌍 His pioneering research on influenza A(H1N1)pdm09 virus infection in pigs has had lasting impacts on veterinary public health. 🦠📖 A committed scholar with 14 peer-reviewed publications, Dr. Er exemplifies the qualities honored by the Pioneer Researcher Award. 🏆✨

Publication  Profile

Orcid

Education 

Dr. Jwee Chiek Er holds a rich academic background dedicated to veterinary science and epidemiology. 🎓🐾 He earned his Ph.D. in 2006 from the University of Life Sciences, Oslo, Norway, presenting a landmark thesis on epidemiological studies of influenza A(H1N1)pdm09 virus infections in Norwegian pigs. 🇳🇴📚 He pursued his Master’s in Preventive Veterinary Medicine (MPVM) at the prestigious University of California, Davis, USA, graduating in 2000 with a focus on Veterinary Epidemiology. 🇺🇸📊 Dr. Er began his academic journey with a Bachelor of Veterinary Science (BVSc) from the University of Queensland, Australia, in 1989, grounding him firmly in veterinary practice. 🇦🇺🩺 His education reflects a lifelong commitment to enhancing animal health and advancing veterinary epidemiology through global learning experiences, interdisciplinary knowledge, and applied research, making him a fitting nominee for the Pioneer Researcher Award. 🏅🌟

Experience 

Dr. Jwee Chiek Er’s professional journey reflects outstanding dedication across diverse fields. 🌟 From 2007 onwards, he has been a full-time researcher at the Norwegian Veterinary Institute, specializing in epidemiology and bioinformatics. 🐷📊 In 2020, he also took on part-time service as a church servant at Uranienborg Menighet, den norsk luthersk kirke. ⛪ Before his research career, Dr. Er served in Singapore’s civil service (1991–2006), ensuring veterinary inspection and public health in pig and poultry slaughterhouses. 🐔🔍 He started his career in national service, where he rose to the rank of Captain in the Singapore Armed Forces as a logistics officer (1989–1991). 🎖️🚛 These extensive experiences demonstrate his leadership, scientific expertise, and commitment to public welfare. His professional background embodies the spirit of perseverance and innovation celebrated by the Pioneer Researcher Award. 🏅📈

Awards and Honors 

Dr. Jwee Chiek Er’s career is a testament to persistent excellence and leadership. 🌟 Although specific award listings were not detailed, his achievements themselves reflect high recognition in the veterinary science community. 🐾📈 His Ph.D. thesis and impactful peer-reviewed publications have significantly advanced knowledge of influenza epidemiology in pig populations, demonstrating award-worthy innovation. 🦠🔬 His pioneering surveillance work on influenza A(H1N1)pdm09 infections in Norway greatly contributed to national animal health strategies. 🇳🇴🐖 Furthermore, Dr. Er’s role in public veterinary service in Singapore and his distinguished service in the Singapore Armed Forces earned him respect and authority early in his career. 🎖️🌏 Nomination for the Pioneer Researcher Award is a fitting tribute to his lifelong dedication to animal health, epidemiological innovation, and scientific leadership. 🏅📚 His work bridges practice and research, influencing veterinary policies across nations. 🌐✨

Research Focus 

Dr. Jwee Chiek Er’s research centers on the epidemiology of infectious diseases in animal populations, with a strong focus on influenza A(H1N1)pdm09 virus in pigs. 🐖🦠 His studies analyze infection patterns, serosurveillance, and economic impacts on animal health, providing essential insights for disease control and public health policy. 📊🛡️ Using bioinformatics and mathematical modeling, such as discrete-time Markov Chain modeling, he projects disease prevalence and evaluates herd-level interventions. 📈🖥️ His research also explores serological cross-reactivity between influenza strains, crucial for improving diagnostic and surveillance systems. 🧬🔍 Through longitudinal studies at boar testing stations and comprehensive serological surveys, Dr. Er has significantly advanced understanding of viral behavior in livestock. 📑📈 His interdisciplinary approach integrating epidemiology, economics, and computational tools highlights him as a pioneer in veterinary research. 🏆🔬 His work supports healthier livestock systems and contributes to global food security. 🌍🍖

Publications Top Notes

  • 📄 “Adverse Effects of Influenza A(H1N1)Pdm09 Virus Infection on Growth Performance of Norwegian Pigs – a Longitudinal Study at a Boar Testing Station” (BMC Vet Res, 2014)

  • 📄 “Occurrence and Spread of Influenza A(H1N1)Pdm09 Virus Infection in Norwegian Pig Herds Based on Active Serosurveillance from 2010 to 2014” (Epidemiol Infect, 2016)

  • 📄 “Production Impact of Influenza A(H1N1)Pdm09 Virus Infection on Fattening Pigs in Norway” (J Anim Sci, 2016)

  • 📄 “Longitudinal Projection of Herd Prevalence of Influenza A(H1N1)Pdm09 Virus Infection in the Norwegian Pig Population by Discrete-Time Markov Chain Modelling” (Infectious Disease Reports, 2021)

  • 📄 “Antibodies of Influenza A(H1N1)Pdm09 Virus in Pigs’ Sera Cross-React with Other Influenza A Virus Subtypes: A Retrospective Epidemiological Interpretation of Norway’s Serosurveillance Data from 2009–2017” (Epidemiology and Infection, 2020)

  • 📄 “A Survey of Skin Neoplasms in Dogs from the Brisbane Region” (Aust Vet J, 1989)

Sheeja Sheela Rajan | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Sheeja Sheela Rajan | Biology and Life Sciences | Best Researcher Award

Dr Sheeja Sheela Rajan, University of Johannesburg, South Africa

Dr. Sheeja Sheela Rajan is a distinguished biochemist with extensive experience in venom pharmacology, molecular biology, and neurobehavioral research. She earned her Ph.D. in Biochemistry from Manonmaniam Sundaranar University, where her thesis on Bungarus caeruleus venom received high acclaim. Currently, she serves as a Postdoctoral Fellow at the Laser Research Centre, University of Johannesburg. Her research spans enzyme purification, coagulation mechanisms, clock gene regulation, and stress neurobiology using Drosophila melanogaster as a model. Dr. Rajan has held academic leadership roles and has taught biochemistry across reputed institutions in India. She is a prolific author, with several peer-reviewed publications in international journals. Passionate about bridging traditional biochemistry with modern biomedical science, she continues to contribute to global health and toxicology. Her achievements and dedication to research excellence make her a strong candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Dr. Sheeja Sheela Rajan completed her Ph.D. in Biochemistry (2010–2015) from Manonmaniam Sundaranar University, Tamil Nadu, India. Her doctoral work focused on the “Pharmacological characterization and purification of dominant enzymes from Bungarus caeruleus venom for coagulation and hemotoxic studies,” earning her high praise and official award in September 2015. She holds an M.Sc. in Biochemistry (2007–2009) from Malankara College, Tamil Nadu, where she investigated “DAZ-1 expression in azoospermic males.” Her strong academic foundation blends molecular biology, enzymology, and toxicology, laying the groundwork for a career in both research and academia. Her interdisciplinary education reflects her ability to integrate classical biochemistry techniques with innovative approaches in behavioral and venom-based biomedical research.

Experience

Dr. Rajan is currently a Postdoctoral Fellow at the Laser Research Centre, Faculty of Health Science, University of Johannesburg (2023–present), exploring stress response and neurobehavior in Drosophila. She previously served as a Postdoctoral Fellow at Annamalai University (2018–2021), researching venom pharmacology and biochemical mechanisms. Her academic career includes roles as Assistant Professor and Head of the Department at Excel College for Commerce and Science (2022–2023) and Dean of Student Affairs at Thievanai Ammal College for Women (2015–2018). Her research journey began as a Research Scholar at Manonmaniam Sundaranar University (2010–2015) and Malankara Catholic College (2007–2009). Dr. Rajan combines academic leadership with experimental expertise in toxicology, molecular biology, and behavioral science.

Awards and Honors

Dr. Rajan was awarded a Postdoctoral Fellowship at Annamalai University (2018–2021) in recognition of her advanced research in biochemistry and venom pharmacology. Her Ph.D. thesis received high commendation for its innovative exploration of hemotoxic enzymes in Bungarus caeruleus venom. She has presented her work at prestigious international and national conferences, including those on biodiversity, chronobiology, and optics. A respected member of the Indian Society for Biological Chemists and the Indian Biochemical Society, she actively contributes to academic discussions and interdisciplinary collaboration. Dr. Rajan’s excellence in teaching and research has earned her recognition in multiple roles, including department head and dean, highlighting her dedication to student mentorship and scientific innovation.

Research Focus

Dr. Sheeja Sheela Rajan’s research bridges venom pharmacology, molecular biology, and neurobehavioral science. Her doctoral research explored the purification and characterization of venom enzymes from Bungarus caeruleus, focusing on their effects on coagulation and hemotoxic pathways. Her postdoctoral work investigates clock genes, stress regulation, and circadian rhythm modulation using Drosophila melanogaster. She studies how food deprivation influences sleep, memory, and sensory responses in fruit flies, using venom components and phenolic compounds to track behavioral and anti-stress responses. Her interest in biochemical pathways conserved between humans and flies positions her research at the forefront of translational studies. With a robust background in toxicology, PCR, cell culture, fluorescence microscopy, and animal models, she contributes significantly to both fundamental and applied biomedical sciences.

Publication Top Notes

Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis

Advancing Photodynamic Therapy with Nano-Conjugated Hypocrellin: Mechanisms and Clinical Applications

Overcoming challenges in cancer treatment: Nano‐enabled photodynamic therapy as a viable solution

SNAKE VENOM-DERIVED PEPTIDES AS PROSPECTIVE PHARMACOLOGICAL TOOLS: RECENT TRENDS

Biological clock and carcinogenesis: role of <i>Lobophora variegata</i> extract on liver cancer

Multidrug Resistance for Cancer Treatment: Delivery of Ursolic Acid and Caffeine by Poly (Lactic-Co-Glycolic Acid) Nanoparticles

Karen Kengne Kamga | Genetics and Genomics | Best Researcher Award

Published on by Research Hypothesis

Karen Kengne Kamga | Genetics and Genomics | Best Researcher Award

Dr Karen Kengne Kamga, Limbe Regional Hospital, south west, Cameroon, Cameroon

Dr. Karen Kengne Kamga is a dynamic physician-scientist from Cameroon, blending clinical expertise with advanced research in human and medical genetics. With an M.D. from the University of Yaoundé I and a Ph.D. in Genetic Counselling from the University of Cape Town, she has become a leading figure in genomic medicine across Africa. She currently serves as a postdoctoral researcher in Human Genetics, Head of Medical Genetics at Limbe Regional Hospital, and Associate Lecturer at the University of Yaoundé I. Passionate about bridging clinical gaps in genetic services in Africa, she’s contributed significantly to fragile X syndrome understanding and healthcare system integration of genetic counselling. Dr. Kamga is a strong advocate for capacity building, precision public health, and equitable genomic research.

Publication Profile

Orcid

Education

Dr. Kamga began her academic journey at GBHS Bafoussam, completing her GCE Ordinary and Advanced Levels. She earned her MD in General Medicine from the University of Yaoundé I in 2013. Driven by a passion for genetics, she pursued a Ph.D. in Genetic Counselling at the University of Cape Town, which she completed in December 2021. To expand her administrative and clinical leadership, she enrolled in an MBA in Health Management at UNICAF University, completed in 2023. She is also pursuing a Master’s in Clinical Genetics at Tech Global University, Andorra (2023–2024). In parallel, she is a postdoctoral fellow in Human Genetics at the University of Cape Town since 2021. Her multi-disciplinary training spans medicine, genetics, health management, epidemiology, and bioinformatics, equipping her to lead innovation in genomic healthcare delivery in low-resource settings.

Experience

Dr. Kamga’s career began as a physician at “Cabinet de soin St Dominique” (2013–2014), followed by multiple leadership roles at District Hospital Limbe from 2014 to 2023, including Head of Pediatrics, Gynecology/Obstetrics, Surgical Unit, ANC & EPI, and Laboratory Coordinator. In 2023, she became Head of Medical Genetics at the Limbe Regional Hospital. Simultaneously, since 2024, she is an Associate Lecturer at the University of Yaoundé I. Her experience reflects a strong commitment to integrating genetic services within mainstream healthcare and public health teaching. Her roles have combined clinical excellence, mentorship, and system-level leadership, all contributing to a national vision for personalized medicine and public health genetics.

Awards and Honors

Dr. Kamga’s research excellence has been widely recognized through prestigious international honors. She received the 2024 Resource-Limited Country Travel Award and the 2021 & 2020 Developing Country Virtual Meeting Awards from the American Society of Human Genetics (ASHG). In 2019, she earned the ASHG Developing Country Travel Award. These honors reflect her impactful presence in the global genetics research community. She is also a respected member of several professional societies: ASHG (since 2020), African Society of Human Genetics (since 2017), and the Cameroon Society of Human Genetics (since 2015). Her accolades underscore a consistent dedication to research, equity, and capacity building in genetic medicine in Africa.

Research Focus

Dr. Kamga’s research focuses on bridging the gap between advanced genetic knowledge and its clinical implementation in Africa. Her Ph.D. investigated cultural perceptions and explanatory models of Fragile X Syndrome in rural Cameroon, highlighting the need for community-sensitive genetic counselling. As a postdoctoral fellow, she explores the integration of human genetics into public health, emphasizing equitable access to genomic services. She led a scoping review identifying strategic pathways to strengthen genetic healthcare in Africa. Her work spans genomic ethics, bioinformatics, genetic education, and precision public health, consistently aiming to enhance genetic literacy and healthcare systems in resource-limited settings. She is deeply involved in collaborative African genomics initiatives like H3Africa, and committed to mentoring emerging scientists.

Publication Top Notes

Advancing Genetic Services in African Healthcare: Challenges, Opportunities, and Strategic Insights from a Scoping Review

Navigating the Genetic Frontier for the Integration of Genetic Services into African Healthcare Systems: A scoping review

Perceptions and preferences for genetic testing for sickle cell disease or trait: a qualitative study in Cameroon, Ghana and Tanzania

Caught between pity, explicit bias, and discrimination: a qualitative study on the impact of stigma on the quality of life of persons living with sickle cell disease in three African countries

Explanatory models for the cause of Fragile X Syndrome in rural Cameroon

Knowledge and Challenges Associated With Hearing Impairment in Affected Individuals From Cameroon (Sub-Saharan Africa)

Negotiating political power and stigma around fragile X Syndrome in a rural village in Cameroon: A tale of a royal family and a community

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Binhui Zhou | Biology and Life Sciences | Best Researcher Award

Assoc. Prof. Dr Binhui Zhou, Institute of Psychiatry and Neuroscience, China

Assoc. Prof. Dr. Binhui Zhou is a leading researcher in molecular biology and neuroscience, renowned for his work in protein palmitoylation and its implications in cancer and immune disorders 🔬🧠. He earned his Ph.D. in Crop Genetics and Breeding from Hainan University and currently serves as an Associate Professor at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University 🎓🏥. With over a decade of research, Dr. Zhou has pioneered studies funded by the National Natural Science Foundation of China and the Henan Provincial Foreign Expert Project 🇨🇳🌟. His groundbreaking publications in top-tier journals have significantly advanced our understanding of cellular signaling in diseases such as hepatocellular carcinoma and atherosclerosis 🧬🩸. A highly respected peer reviewer for prestigious journals, he continues to shape the scientific community through innovation and collaboration 🤝📚. Dr. Zhou exemplifies excellence in research and stands as a deserving candidate for the Best Researcher Award 🏆✨.

Publication Profile

Orcid

Education

Dr. Binhui Zhou’s educational journey reflects his strong commitment to bioscience and innovation 📘🧪. He began his academic career with a Bachelor’s degree in Bioengineering from Ningbo Institute of Technology, Zhejiang University (2005–2009) 🎓🔍. His passion for molecular and developmental biology led him to complete a Master’s degree in Developmental Biology at Hainan University (2010–2013), where he gained key insights into cell and tissue growth processes 🌱🧫. He pursued his Ph.D. at the same university in Crop Genetics and Breeding (2013–2017), where his research laid the foundation for his later studies on genetic regulation and disease pathways 🌾🧬. Throughout his education, Dr. Zhou displayed academic excellence, research depth, and a clear focus on translating fundamental biology into clinical relevance. His multidisciplinary academic background supports his current role as a prominent scientist exploring intersections of genetics, immunology, and neuroscience 🔍📖🧠.

Experience

Dr. Zhou began his academic career in 2017 as a Lecturer at the Institute of Neuropsychiatry and Neuroscience, Xinxiang Medical University 🏫🧠. Over seven years, he demonstrated outstanding research and teaching capabilities, contributing significantly to the fields of molecular biology and neuroimmunology 📚🔬. In 2024, he was promoted to Associate Professor in recognition of his impactful work on palmitoylation mechanisms and their clinical relevance in hepatocellular carcinoma and immune regulation 🧬🩺. His leadership in major research projects, such as NSFC Youth Program and Henan Foreign Expert Project, highlights his ability to lead innovative studies with real-world implications 🌍📊. In parallel, Dr. Zhou has served as a mentor to young scientists, shaping the next generation of researchers 👨‍🏫🌱. His dedication to cross-disciplinary collaboration and translational science continues to position him at the forefront of biomedical research.

Awards and Honors

Assoc. Prof. Dr. Binhui Zhou has received national recognition for his exceptional contributions to biomedical science 🧬🌟. As a Principal Investigator, he secured prestigious research grants, including the NSFC Youth Program and the Henan Provincial Foreign Expert Project, reflecting his leadership and innovation in high-impact studies 💡🧠. His work has been published in top-tier journals such as Cell Molecular Immunology, Theranostics, and Journal of Advanced Research, each with high impact factors and broad influence in global science communities 📈🌐. As an expert reviewer for journals like Communications Biology and Cell Communication and Signaling, he has helped uphold the integrity and quality of scientific publishing 📘🧪. Moreover, Dr. Zhou was appointed as a reviewer for the NSFC Youth Program, a mark of his standing in China’s scientific elite 🇨🇳📜. These accolades affirm his merit for the Best Researcher Award 🏅👏.

Research Focus

Dr. Zhou’s research primarily explores protein palmitoylation, a lipid modification process critical in regulating cellular signaling pathways in diseases such as cancer, atherosclerosis, and immune dysfunctions 🧪🧠. He focuses on zDHHC family palmitoyltransferases, particularly zDHHC1, zDHHC2, and zDHHC6, and their roles in modulating protein function in hepatocellular carcinoma and inflammatory responses 🔬🧬. His investigations have revealed mechanisms by which these enzymes control immune cell behavior and cancer cell proliferation, contributing to therapeutic target discovery 💊🔍. Notably, his studies on Foxp3 palmitoylation have uncovered novel immune regulatory pathways. Dr. Zhou also examines the PI3K-Akt-mTOR axis in relation to atherosclerosis, offering insights into cardiovascular disease treatment 🫀📊. His interdisciplinary approach bridges molecular biology, immunology, and neuroscience, pushing the boundaries of biomedical knowledge and guiding new treatment strategies across multiple health conditions 🤝🌍. His research stands at the forefront of cellular signaling and translational medicine 🚀🧫.

Publication Top Notes

Distinct palmitoylation of Foxp3 regulates the function of regulatory T cells via palmitoyltransferases

Protein palmitoylation in cancer: molecular functions and therapeutic potential

The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma

A Murine Point Mutation of Sgpl1 Skin Is Enriched With Vγ6 IL17-Producing Cell and Revealed With Hyperpigmentation After Imiquimod Treatment

Excessive immunosuppression by regulatory T cells antagonizes T cell response to schistosome infection in PD-1-deficient mice

sgRNA Knock-in Mouse Provides an Alternative Approach for In Vivo Genetic Modification

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Published on by Research Hypothesis

Buddhi Fernando | Biology and Life Sciences | Best Researcher Award

Dr Buddhi Fernando, Department of MLS, Faculty of Allied Health Sciences, University of Ruhuna, Galle, Sri Lanka

Dr. Buddhi Fernando is a dedicated academic and clinical biochemist from Sri Lanka 🇱🇰, currently serving as a Lecturer at the Department of Medical Laboratory Science, Faculty of Allied Health Sciences, University of Ruhuna. With a Ph.D. in Clinical Biochemistry from the University of Peradeniya 🎓, Dr. Fernando has pioneered studies on Chronic Kidney Disease of uncertain etiology (CKDu), identifying biomarkers for diagnosis, staging, and risk prediction 🧬🩺. With experience in teaching Clinical Biochemistry, Andrology, Microbiology, and more, she has inspired many students while conducting impactful research. Her award-winning research presentations and global exposure, including a scholarship to Japan 🌏, reflect her academic excellence. Dr. Fernando has co-authored numerous high-impact publications in reputed journals and remains passionate about translational science that directly benefits vulnerable communities. Her persistent pursuit of knowledge, interdisciplinary collaborations, and commitment to public health place her among Sri Lanka’s most promising researchers 🌟📚🔬.

Publication Profile

Google Scholar 

Education

Dr. Buddhi Fernando completed her Ph.D. in Clinical Biochemistry 🧪 at the Faculty of Medicine, University of Peradeniya, Sri Lanka, in 2020. Her dissertation focused on identifying a biomarker profile for CKDu and evaluating its utility in early diagnosis, staging, and risk stratification 🧬📊. She earned her B.Sc. in Medical Laboratory Science with a Second-Class Upper Division in 2014 from the Faculty of Allied Health Sciences, University of Peradeniya 🏥🔍. Her undergraduate research explored the impact of Diabetes Mellitus on heart function in ICR mice 🐭❤️. Earlier, she completed the G.C.E. Advanced Level Examination (2008) and G.C.E. Ordinary Level Examination (2002) with commendable results 🎓📘. Dr. Fernando’s academic training merges rigorous scientific methodology with a strong focus on public health relevance, especially in addressing rural disease burdens. Her scholarly foundation has been crucial in supporting her innovative research into CKDu, a condition affecting thousands in Sri Lanka 🩺🌱.

Experience

Dr. Buddhi Fernando has over six years of academic and teaching experience 📚. From November 2019 to date, she has served as a Lecturer (Probationary and then permanent) at the Department of Medical Laboratory Science, University of Ruhuna 🏫. Her teaching responsibilities span Clinical Biochemistry, Microbiology, Andrology, Physiology, and Parasitology 🧫🧠. She has also taken on leadership roles as Batch Coordinator and Unit Coordinator. Previously, she was a Demonstrator at the University of Peradeniya (2018–2019) and a Lecturer at IVA Para Medical Campus, Kandy (2018) 🧪. She is registered with the Sri Lanka Medical Council (Reg. No. 2478) 🧾. Her hands-on academic guidance and innovative methodologies help bridge theoretical learning with practical healthcare applications. Dr. Fernando’s commitment to education and mentorship has left a positive impact on future generations of medical laboratory professionals.

Awards and Honors

Dr. Buddhi Fernando’s excellence in research and academia has earned her several prestigious accolades 🌟. In 2012, she was awarded a scholarship for the Global Health Student Exchange Program at Niigata University, Japan, recognizing her early promise in global public health 🌍🇯🇵. In 2017, she won First Place for the Best Oral Presentation at the Research Sessions of the Kandy Society of Medicine 🥇🎤, showcasing her talent in communicating scientific breakthroughs effectively. Her outstanding scholarly output is reflected in numerous publications across high-impact journals such as PLoS ONE, Kidney International Reports, and Environmental Geochemistry and Health 📑📈. As a unit coordinator and mentor, her academic leadership has also been instrumental in enhancing research culture among peers and students 🧑‍🎓🔬. These honors exemplify her capability to contribute significantly to science, education, and community health — making her a strong contender for the Best Researcher Award 🏅📚🧪.

Research Focus

Dr. Buddhi Fernando’s research primarily centers on Chronic Kidney Disease of uncertain etiology (CKDu)—a pressing health crisis in Sri Lanka’s rural communities 🏞️🩺. Her Ph.D. work focused on identifying biomarker templates for CKDu and evaluating their utility for early detection, population screening, diagnosis, staging, and predicting complications 🧬💉. Her multidisciplinary approach integrates biochemical profiling, environmental toxicology, and molecular diagnostics to uncover the complex pathophysiology of CKDu. Beyond CKDu, she also explores diabetes-related cardiac effects and trace element imbalances ⚖️❤️. Dr. Fernando’s work has high translational value, aiming to bridge the gap between laboratory science and community health solutions 🧪🤝. Her collaborations with nephrologists, toxicologists, and global health experts reflect her broad academic network and research adaptability 🌐. Her contributions are vital to designing affordable, effective diagnostics for low-resource settings — making her research both locally relevant and globally significant 🌎📊🧠.

Publication Top Notes

Serum and urine fluoride levels in populations of high environmental fluoride exposure with endemic CKDu: a case–control study from Sri Lanka

 

Robert Nshimiyimana | Molecular Biology | Best Researcher Award

Published on by Research Hypothesis

Robert Nshimiyimana | Molecular Biology | Best Researcher Award

Dr Robert Nshimiyimana, Harvard Medical School, United States

Dr. Robert Nshimiyimana is a postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School, specializing in organic chemistry, biochemistry, and molecular biology. His research explores the identification of bioactive chemical signals, pathways, and cellular targets that enhance the innate resolution of inflammation. His contributions to inflammation resolution research have provided critical insights into therapeutic strategies for diseases driven by chronic inflammation. With expertise in mass spectrometry, nuclear magnetic resonance spectroscopy, and lipidomics, he plays a pivotal role in deciphering pro-resolving mediators in human biology. His work has resulted in multiple high-impact publications and recognition at prestigious international conferences. Passionate about mentoring and scientific outreach, Dr. Nshimiyimana is committed to advancing biomedical research and fostering collaborations to translate laboratory discoveries into clinical applications. His dedication to excellence and groundbreaking research make him a strong candidate for the Best Researcher Award.

Publication Profile

Google Scholar

Education

Dr. Robert Nshimiyimana holds a Ph.D. in Organic Chemistry from the University of Southern California (USC), where he conducted cutting-edge research in bioorganic synthesis and lipid mediators of inflammation. His doctoral work focused on developing synthetic pathways for bioactive molecules that regulate the inflammatory response. Prior to that, he earned a B.A. in Biochemistry and Molecular Biology from Hendrix College, where he gained foundational expertise in chemical biology and enzymology. As part of his academic journey, Dr. Nshimiyimana participated in an International Student Exchange Program (ISEP) at Ulster University, Northern Ireland, broadening his scientific perspective and fostering global collaborations. His multidisciplinary education in chemistry, molecular biology, and biochemistry has provided him with a unique skill set to tackle complex biomedical challenges. His academic excellence and research contributions have established him as a rising leader in inflammation resolution and lipidomics research.

Experience

Dr. Robert Nshimiyimana has held multiple prestigious research positions, including his current role as a postdoctoral research fellow at Brigham and Women’s Hospital and Harvard Medical School. Here, he investigates pro-resolving lipid mediators and their role in inflammation resolution. 📚 During his Ph.D. at USC, he served as a graduate research associate, focusing on the total synthesis of bioactive molecules and their impact on cellular signaling pathways. His research contributed to developing novel therapeutics targeting chronic inflammatory diseases. 👨‍🏫 Additionally, he has served as an instructor and teaching assistant for organic chemistry and biochemistry, mentoring students in advanced analytical techniques such as NMR, mass spectrometry, and chromatography. 💡 His expertise in chemical biology, lipidomics, and bioorganic chemistry has positioned him as a leading scientist in the study of inflammation and disease mechanisms, making him a prime candidate for the Best Researcher Award.

Awards and Honors

Dr. Robert Nshimiyimana has been recognized with numerous prestigious awards, highlighting his impactful contributions to biomedical research. ✨ He received the Best Oral Presentation Award at the 16th World Congress on Inflammation, showcasing his expertise in pro-resolving lipid mediators. ✈️ He was also awarded the Eicosanoid Research Foundation (ERF) Travel Award, enabling him to present groundbreaking research on lipid mediators and inflammation resolution at leading international conferences. 🔬 Beyond research, he serves as a peer reviewer for renowned journals, including Current Organic Chemistry, Current Materials Science, and Tetrahedron Letters, contributing to scientific advancement. His dedication to biomedical innovation, mentorship, and scholarly excellence has earned him global recognition. His commitment to advancing inflammation research through novel therapeutic strategies cements his reputation as a top-tier researcher and a deserving recipient of the Best Researcher Award.

Research Focus

Dr. Robert Nshimiyimana’s research focuses on the identification of bioactive chemical signals, pathways, and cellular targets responsible for stimulating the innate resolution of inflammation. His work integrates organic chemistry, biochemistry, and molecular biology to investigate how lipid mediators regulate immune responses and promote tissue healing. 🔍 Using advanced analytical techniques like mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy, he studies the biosynthesis and function of pro-resolving mediators such as resolvins, maresins, and lipoxins. His research aims to develop therapeutic interventions targeting inflammatory diseases, including arthritis, pneumonia, and lung injury. 🌎 His innovative studies have profound clinical implications, potentially leading to new treatments for chronic inflammatory disorders. With a track record of high-impact publications and groundbreaking discoveries, Dr. Nshimiyimana is at the forefront of inflammation resolution research, making him an exceptional candidate for the Best Researcher Award.

Publication Top Notes

A new E-series resolvin: RvE4 stereochemistry and function in efferocytosis of inflammation-resolution

E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for …

Elovanoids counteract oligomeric β-amyloid-induced gene expression and protect photoreceptors

Human leukocytes selectively convert 4S,5S-epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer

Stereospecific metabolism of R-and S-warfarin by human hepatic cytosolic reductases

Infectious neutrophil deployment is regulated by resolvin D4

ELV-N32 and RvD6 isomer decrease pro-inflammatory cytokines, senescence programming, ACE2 and SARS-CoV-2-spike protein RBD binding in injured cornea

Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome

Ahmed Idris Hassen | Biotechnology | Best Researcher Award

Published on by Research Hypothesis

Prof. Ahmed Idris Hassen | Biotechnology | Best Researcher Award

Research Scientist at Agricultural Research Council, South Africa

Dr. Ahmed Idris Hassen is a Researcher at the Agricultural Research Council, South Africa, and an Adjunct Professor in Applied Microbiology at the University of Venda. He holds a Ph.D. in Microbiology and Plant Pathology from the University of Pretoria and has extensive expertise in soil microbiology, rhizobium-legume symbiosis, plant-microbe interactions, and biofertilizer development. A C-3 rated scientist by the National Research Foundation (NRF), he has led multiple projects on rhizobial inoculants, drought tolerance, and soil health. With over 1,100 citations and a strong Scopus & Google Scholar presence, his research significantly contributes to sustainable agriculture. 🌱📚✨

Publication Profile

Orcid

Educational Background🎓

Dr. Ahmed Idris Hassen holds a Ph.D. in Microbiology and Plant Pathology from the University of Pretoria, South Africa (2003-2007), where his research focused on the efficacy of plant growth-promoting rhizobacteria for biocontrol and growth promotion in sorghum. He earned his M.Sc. in Applied Microbiology from Addis Ababa University, Ethiopia (1998-1999), investigating the microbiological and biochemical aspects of traditional food fermentation. His academic journey began with a B.Sc. in Biology from the University of Asmara, Eritrea (1986-1989), followed by secondary education in Addis Ababa, Ethiopia (1982-1985). His expertise spans microbial interactions, soil health, and plant pathology. 🌱🔬📚

Professional Background👨‍🏫

Dr. Ahmed Idris Hassen is an Adjunct Professor at the University of Venda, South Africa (2023–Present), contributing to research in Plant and Soil Sciences. Since 2009, he has been a Researcher in Applied and Soil Microbiology at the Agricultural Research Council, focusing on plant health and protection. Previously, he held a postdoctoral fellowship (2008-2009) at the University of Pretoria, working on plant growth-promoting rhizobacteria (PGPR). He also served as a Senior Research Assistant (2007-2008) and Lecturer in Microbiology at Haramaya University (1999-2003). His early career included secondary school biology teaching (1990-1997). 🌱🔬📚

Research Focus 🔬

Dr. Ahmed Idris Hassen specializes in Soil Microbiology and Plant-Microbe Interactions, focusing on rhizosphere health and biological nitrogen fixation. His research explores Rhizobium-legume symbiosis 🌱, microbial community diversity 🦠, and biocontrol mechanisms against phytopathogens 🍄. He applies molecular techniques 🧬, including 16S rRNA sequencing, metagenomics, and whole genome analysis for microbial characterization. His work on plant growth-promoting rhizobacteria (PGPR) enhances sustainable agriculture 🌾 through biofertilizers and microbial inoculants. Dr. Hassen also investigates microbial indicators of soil health and antibiosis mechanisms in plant disease control, contributing to eco-friendly agroecosystems 🌍.

Publication Top Notes

Identification of a biomarker for Bacillus thuringiensis strains with high toxicity against Spodoptera frugiperda 🦟🔬
Year: 2024

Symbiotic Performance and Characterization of Pigeonpea (Cajanus cajan) Rhizobia Occurring in South African Soils 
Year: 2022

Efficacy of Peat and Liquid Inoculant Formulations of Bradyrhizobium japonicum Strain WB74 on Growth, Yield and Nitrogen Concentration of Soybean (Glycine max) 🌾🧪
Year: 2021

Conclusion

Dr. Ahmed Idris Hassen is a distinguished researcher in soil microbiology, plant-microbe interactions, and sustainable agriculture, with over 15 years of experience. As a leader in multiple nationally and internationally funded projects, he has made significant contributions to biocontrol, biofertilizers, and rhizobium-legume interactions. Holding a National Research Foundation (NRF) C-3 rating, his research impact extends globally, reflected in his extensive publication record in reputable journals like Microorganisms, Scientific African, and Pest Management Science. With a Google Scholar H-index of 14, i10-index of 19, and 1169 citations (Scopus H-index: 10), his influence in the field is well-established. Additionally, as an Adjunct Professor at the University of Venda, he actively contributes to academia through teaching and mentorship. His innovations, including the development of elite rhizobial inoculants for commercial agriculture, further underscore his impact on scientific and industrial advancements, making him a highly deserving candidate for the Best Researcher Award. 🚀